Operating
Change in Inventories
Eli Lilly Change in Inventories remained flat by 0.0% to $1.17B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 86.3%, from $626.75M to $1.17B. Over 4 years (FY 2021 to FY 2025), Change in Inventories shows an upward trend with a 110.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025Feb 12, 2026
How to read this metric
A decrease is often positive as it signals efficient inventory turnover and cash release, provided it does not lead to stockouts.
Detailed definition
This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...
Peer comparison
Highly dependent on industry; manufacturing and device companies typically maintain higher inventory levels than software firms.
Metric ID:
change_in_inventoriesHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $235.90M | $599.70M | $1.43B | $2.51B | $4.67B |
| YoY Change | — | +154.2% | +137.6% | +75.9% | +86.3% |
Range$235.90M – $4.67B
CAGR+110.9%
Avg YoY Growth+113.5%
Median YoY Growth+112.0%
Current Streak4+ years growth
Change in Inventories at Other Companies
Frequently Asked Questions
- What is Eli Lilly's change in inventories?
- Eli Lilly (LLY) reported change in inventories of $1.17B in Q4 2025.
- How has Eli Lilly's change in inventories changed year-over-year?
- Eli Lilly's change in inventories increased by 86.3% year-over-year, from $626.75M to $1.17B.
- What is the long-term trend for Eli Lilly's change in inventories?
- Over 4 years (2021 to 2025), Eli Lilly's change in inventories has grown at a 110.9% compound annual growth rate (CAGR), from $235.90M to $4.67B.
- What does change in inventories mean?
- The change in the value of products and materials held in stock.